(800) 526-OPYS Pay my bill Member login
logo
OPYS 10 years
  • Hospital Solutions
    • Emergency Medicine
    • Hospital Medicine
    • Telemedicine
    • Urgent Care
    • Post Acute Care
    • Correctional Medicine
    • Locum Tenens
  • Join our Team
    • Physicians
    • Advanced Practitioners
    • Career Opportunities
  • About OPYS
    • Experienced Group
    • Metrics & Outcomes
    • Throughout the US
    • Quality Patient Care
    • Clinical Performance
    • Qualified Providers
    • Company Profile
    • Leadership Team
    • Mission Statement
    • Reviews
  • News
  • Contact Us

Can Antidepressants Prevent Severe COVID-19?

Home > Best Practice > Can Antidepressants Prevent Severe COVID-19?

Can Antidepressants Prevent Severe COVID-19?

January 26, 2023

Since the COVID-19 pandemic began, physicians and researchers have investigated the factors that predict how well people manage COVID-19 once infected and have looked to the potential effects of existing drugs on COVID-19 severity. A new study published in Molecular Psychiatry highlights the possibility that psychiatric medication may be beneficial for those combatting COVID-19.

The new study was based on previous research that had suggested that people living with major depressive disorder who took antidepressants are more likely to have lower plasma levels of certain pro-inflammatory mediators that have been linked to severe COVID-19. The idea of antidepressants playing a potentially protective role in COVID-19 had also been bolstered by mechanistic data suggesting that antidepressants could inhibit the activity of acid sphingomyelinase, which could prevent epithelial cells from becoming infected with SARS-CoV-2.

The researchers for the Molecular Psychiatry study evaluated the impact of antidepressants using data from adults who had been hospitalized for COVID-19. Of the 7,230 adults analyzed, 345 of them received antidepressants in the first 2 days of hospitalization. The results showed that hospitalized COVID-19 patients who received antidepressants were significantly less likely to be intubated or die than those who did not take antidepressants while hospitalized.

Upon digging further, the researchers also found that the association between antidepressants and reduced risk of intubation and death existed for both serotonin selective reuptake inhibitors (SSRIs) as well as non-SSRI antidepressants. Specifically, fluoxetine, paroxetine, escitalopram, venlafaxine, and mirtazapine all appeared to improve the likelihood of recovering from COVID-19 without intubation.

These results suggest that antidepressants may be beneficial for preventing severe COVID-19. However, more research is needed to determine the role that these drugs may play in fighting COVID-19 now and in the future.

 

 

Reference

Hoertel N, Sánchez-Rico M, Vernet R, et al. Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study. Molecular psychiatry. Published online 2021. doi:10.1038/S41380-021-01021-4

Filed Under: Best Practice, COVID-19, General, Patient Care, Public Health Tagged With: Coronavirus, COVID-19, Health care, Medications, Mental Health, OPYS, patient care

Search

Categories

  • Best Practice
  • Cardiologists
  • COVID-19
  • Emergency Physicians
  • General
  • Health Technology
  • Hospital Physicians
  • Hospitalists
  • New Job Opportunities
  • Nurses
  • Patient Care
  • Physician Job
  • Physician Services News
  • Public Health
  • Reimbursement
  • Telehealth Blog Series
  • Women's Health

Archives

  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • April 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • September 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • December 2017
  • March 2017
  • June 2016
  • August 2015
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011

We’d Love to Hear From You,
Get In Touch With Us!

logo

Since 2012, providing quality, efficient, patient-centered healthcare through experienced medical leadership, communication, and collaboration in the provision of hospital-based physician outsourcing services.

Our Services
  • Emergency Medicine
  • Hospital Medicine
  • Telemedicine
  • Urgent Care
  • Post Acute Care
  • Correctional Medicine
OPYS Advantage
  • Our Team
  • Investor Relations
  • Career Opportunities
Contact
Corporate Office 

One Indiana Square, Suite 2060
Indianapolis, IN 46204

Phone: (800) 526-6797
Fax: (800) 456-6148
Email: info@opys.com

Copyright © 2012 - 2022. All rights reserved I Site Map I Privacy Policy I Terms and Use